Evotec News - Evotec Website (English)
WEBIt is a prime concern of Evotec that all relevant target groups receive the same information at the same time. This implies communicating in both English and German. Here you will find the most recent corporate news, ad hoc releases …
Evotec reports Q1 2024 results and provides corporate update
WEBMay 22, 2024 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced financial results and corporate updates for the first quarter 2024. HIGHLIGHTS. EVOTEC’S TRANSACTIONAL BUSINESS IMPACTED BY HEADWINDS; STRONG GROWTH IN JUST – EVOTEC BIOLOGICS
Evotec SE reports H1 2024 results: Challenging year; priority reset …
WEBAug 14, 2024 · Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Investor Relations & Evotec News - Evotec Website (English)
WEBAug 13, 2024 · IR & News Welcome to the Evotec newsroom. Here you can find all Investor Relations information, which events Evotec will be attending, all recent new releases and sign up for regular scientific updates.
Together for Medicines That Matter - Evotec Website (English)
WEBEvotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.
Evotec announces change in Management Board
WEBSep 3, 2024 · Evotec SE today announced that its Chief Business Officer, Dr Matthias Evers, has decided to step down to pursue opportunities outside of Evotec. He will leave the Company effective 01 October 2024. Matthias was appointed Chief Business Officer of Evotec on 01 May 2022.
Evotec Stock Information - Evotec Website (English)
WEBEvotec intends to retain all available funds and any future earnings and reinvest them in the company’s further growth strategy to better leverage long-term growth and sustainability.
About Us | Evotec - Evotec Website (English)
WEBAt Evotec, we are at the forefront of a healthcare paradigm shift, driven by our commitment to reshaping the future of medicine: Together for medicines that matter. This sentence contains everything you need to know about Evotec – our what, our how, and our why.
PerkinElmer to Acquire Evotec Technologies
WEBHamburg, Germany | Oxford, UK - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) yesterday evening announced that PerkinElmer Inc. (NYSE: PKI) signed a definitive agreement to acquire Evotec Technologies GmbH in a cash transaction valued at approximately EUR 23 million.
Evotec and Pfizer collaborate to advance drug discovery in France
WEBEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced it has entered into a multi-year master research collaboration and option and license agreement with Pfizer. Under the agreement, Evotec and Pfizer will initially focus on early discovery research for …